Remaining unmet needs in diverse populations with mHSPC

Future Research Directions

Key Themes:

• There is a need for continued efforts to improve minority enrollment in clinical trials.
• The importance of real-world evidence to complement trial data is growing.
• A combined approach should use trial and real-world data for comprehensive assessment.
• Future research should prioritize diversity and representation.

Key Points for Physicians:

• Stay informed about evolving evidence from clinical trials and real-world data.
• Support efforts to improve diversity in research.
• Consider contributing to real-world evidence generation.
• Recognize limitations in current evidence while awaiting more comprehensive data.

Notable Insights: Real-world evidence provides an important complement to clinical trial data, particularly for understanding outcomes in traditionally underrepresented populations.

Clinical Significance: Ongoing commitment to inclusive research and evidence generation will improve the quality and equity of prostate cancer care, particularly for populations historically underrepresented in clinical trials.